stockrowFortrea Holdings Inc.
FTRE Healthcare Biotechnology
Fortrea Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 1.00% from fiscal 2024.
- Revenue
- −1.40%
- EPS
- +103.7%
- Free cash flow
- −34.0%
- Total debt
- −6.33%
Quarter to September 2026, against a year earlier
Follow FTRE
Alert me
Fortrea Holdings Inc. (FTRE) Gross margin
Fortrea Holdings Inc.'s gross margin over the twelve months to 30 September 2026 was 20.0%, up 1.5 percentage points from fiscal 2025 (18.5%). Over the past ten years it has ranged from 14.3% (fiscal 2020) to 25.5% (fiscal 2022); the current reading is higher than 33% of that period. That is below the Biotechnology industry median of 68.5% and below the Healthcare sector median of 54.5%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 18.5% | (1.31) |
| FY2024 | 19.8% | (0.97) |
| FY2023 | 20.8% | (4.75) |
| FY2022 | 25.5% | 5.76 |
| FY2021 | 19.8% | 5.43 |
| FY2020 | 14.3% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 20.2% | (0.35) |
| Jun 2026 | 20.5% | 1.10 |
| Mar 2026 | 19.4% | (0.43) |
| Dec 2025 | 19.9% | 2.35 |
| 13 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| IMNM Immunome, Inc. compare | 100.0% |
| VIR Vir Biotechnology, Inc. compare | 100.0% |
| HRMY Harmony Biosciences Holdings, Inc. compare | 74.0% |
| FTRE Fortrea Holdings Inc. | 20.0% |
| SRPT Sarepta Therapeutics, Inc. compare | 0.00% |
| REPL Replimune Group, Inc. compare | 0.00% |
| BHVN Biohaven Ltd. compare | 0.00% |
| ZYME Zymeworks Inc. compare | −246.7% |
| TRAX First Tracks Biotherapeutics, Inc. compare | — |
| Biotechnology industry median | 68.5% |
| Healthcare sector median | 54.5% |
| Market median | 46.0% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue